(Q45474114)

14 December 2017

title

Combination therapy with interferon-alpha and ribavirin in patients with dual hepatitis B and hepatitis C virus infection (English)

1 reference

14 December 2017

0 references

1 reference

1 reference

Chao-Hung Hung

1

1 reference

14 December 2017

Chuan-Mo Lee

2

1 reference

14 December 2017

Sheng-Nan Lu

3

1 reference

14 December 2017

Jing-Houng Wang

4

1 reference

14 December 2017

Hung-Da Tung

5

1 reference

14 December 2017

Chien-Hung Chen

6

1 reference

14 December 2017

Chi-Sin Changchien

7

1 reference

14 December 2017

publication date

1 May 2005

1 reference

Journal of Gastroenterology and Hepatology

14 December 2017

published in

1 reference

14 December 2017

volume

20

1 reference

14 December 2017

issue

5

1 reference

14 December 2017

page(s)

727-732

1 reference

Role of hepatitis C virus in dual and triple hepatitis virus infection

14 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2005.03791.X

Hepatitis C Virus Infection in Chronic Hepatitis B Virus Carriers

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2005.03791.X

Characteristics of patients with dual infection by hepatitis B and C viruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2005.03791.X

Replication status and histological features of patients with triple (B, C, D) and dual (B, C) hepatic infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2005.03791.X

Interferon alfa-2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C. Hepatitis Interventional Therapy Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2005.03791.X

Interferon alfa-2b alone or in combination with ribavirin for the treatment of relapse of chronic hepatitis C. International Hepatitis Interventional Therapy Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2005.03791.X

Pilot study of combination therapy with ribavirin and interferon alfa for the retreatment of chronic hepatitis B e antibody-positive patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2005.03791.X

Alpha-interferon therapy in chronic hepatitis due to active dual infection with hepatitis B and C viruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2005.03791.X

Ribavirin and interferon is effective for hepatitis C virus clearance in hepatitis B and C dually infected patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2005.03791.X

Is delayed normalization of alanine aminotransferase a poor prognostic predictor in chronic hepatitis C patients treated with a combined interferon and ribavirin therapy?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2005.03791.X

Mutations in the NS5A and E2-PePHD region of hepatitis C virus type 1b and correlation with the response to combination therapy with interferon and ribavirin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2005.03791.X

Concurrent hepatitis B and C virus infection: Is hepatitis C virus stronger?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2005.03791.X

Reactivation of hepatitis B virus infection induced by interferon (IFN) in HBsAg-positive, antiHCV-positive patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2005.03791.X

Meta-analysis of interferon randomized trials in the treatment of viral hepatitis C: Effects of dose and duration

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2005.03791.X

High Doses of alpha-Interferon Are Required in Chronic Hepatitis Due to Coinfection With Hepatitis B virus and hepatitis C virus: long term results of a prospective randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2005.03791.X

10.1111/J.1440-1746.2005.03791.X

21 January 2018

Identifiers

DOI

1 reference

14 December 2017

1 reference